INSIGHT

AI Discoverability for Life Sciences Organizations

Why being visible is no longer enough when AI systems increasingly mediate how people find, interpret, and compare organizations and expertise.

Juan A. Flores, Co-Founder and CDO at JUYMO & Co.By Juan A. Flores – Published February 18, 2025

Discoverability Has Acquired Another Layer

For most organizations, digital discoverability has historically meant being present where people search: search engines, professional platforms, industry publications, scientific databases, corporate websites, and other relevant channels. Those channels have not disappeared, but people can now ask an AI system a question and receive a synthesized answer assembled from information that may come from many different sources.

That creates a different problem for organizations. Being present online does not necessarily mean being represented accurately when information about the organization, its people, or its expertise is retrieved and synthesized. For life sciences organizations, where credibility and precision matter, that distinction deserves attention.

What AI Discoverability Actually Means

I use AI discoverability to describe an organization's ability to be found and represented appropriately within AI-mediated discovery. This is broader than appearing in an AI-generated answer. The more important question is whether sufficient reliable information exists for an AI system to form a useful picture of the organization: what it does, what expertise it has, who stands behind that expertise, and how its areas of knowledge relate to one another.

That picture will never be entirely under an organization's control. AI systems draw on different sources, retrieval methods, models, and information environments, while external publications, regulatory information, scientific literature, media coverage, professional profiles, and other third-party sources can all contribute. AI discoverability therefore cannot be reduced to optimizing a website.

AI discoverability therefore cannot be reduced to optimizing a website.

— Juan A. Flores

The Life Sciences Challenge Is Fragmentation

Life sciences organizations generate enormous amounts of information, but that information often lives in different places and serves very different purposes. Corporate information may sit on one platform, scientific evidence on another, product information somewhere else, executive expertise on professional networks, regulatory information with authorities, and market-specific materials across multiple local environments.

Terminology can also vary between global and local teams, functions, therapeutic areas, products, indications, and stages of development. That fragmentation is understandable from an organizational perspective, but from the outside it can make the organization harder to interpret.

The problem becomes particularly relevant when an AI system is expected to connect information rather than simply locate one page. It may need to distinguish between the company and a product, between corporate expertise and an individual's expertise, between an approved indication and a broader disease area, or between current information and something that has become outdated. AI discoverability therefore begins with clarity, not volume.

Consistency Matters, but Repetition Is Not the Objective

There is a temptation to respond to AI discoverability by repeating the same terminology everywhere. I think that misses the point. Organizations should communicate naturally to different audiences and in different contexts: a scientific publication should not sound like a corporate profile, and an executive article should not be written like product information simply to reinforce the same terminology.

What should remain consistent is the underlying meaning. Names, roles, areas of expertise, organizational relationships, product terminology, important concepts, and factual descriptions should not contradict one another unnecessarily. Related information should connect logically, and significant changes should propagate across the places where outdated information could create confusion.

Names, roles, areas of expertise, organizational relationships, product terminology, important concepts, and factual descriptions should not contradict one another unnecessarily.

— Juan A. Flores

This is less about forcing semantic repetition than about reducing avoidable ambiguity.

Authority Cannot Be Manufactured Internally

Organizations can explain what they know, but they cannot simply declare themselves authoritative and expect that declaration to carry equal weight everywhere. Credibility is built through evidence, which in life sciences may include scientific publications, regulatory sources, clinical evidence, recognized experts, conference participation, professional history, credible external coverage, partnerships, institutional affiliations, and substantive work that demonstrates expertise.

This matters for AI discoverability because an organization's own digital presence is only part of the information environment from which it may be interpreted. A strong corporate website with weak external corroboration is not the same thing as a credible body of evidence distributed across reliable sources.

This matters for AI discoverability because an organization's own digital presence is only part of the information environment from which it may be interpreted.

— Juan A. Flores

People Are Part of the Information Architecture

Expertise belongs to people as well as organizations. When executives or specialists publish, speak, write books, participate in industry discussions, lead substantial work, or develop recognized expertise, those activities contribute to how both they and the organization can be understood. Clear authorship also helps distinguish corporate claims from individual expertise and perspective.

This does not mean attaching a founder's name mechanically to every strategic topic. That creates noise rather than authority. The useful connection is a truthful one: which people genuinely know about which subjects, what demonstrates that expertise, and how does their work relate to the organization?

For life sciences companies built around specialist knowledge, making those relationships clear can be particularly valuable.

Structured Data Helps Machines Read What Is Already There

Structured data has an important but sometimes exaggerated role in this discussion. It can make explicit relationships already present in visible content: this person works for this organization, this article was written by this author, this page describes this organization, or these profiles refer to the same entity.

That is useful machine-readable infrastructure, but it is not a substitute for substantive content, credible authority, or technical accessibility. Good structured data clarifies reality. It should not attempt to manufacture one.

The same principle applies more broadly to AI discoverability. Technical implementation can help machines access and interpret information, but it cannot compensate indefinitely for unclear positioning, contradictory content, weak evidence, or an organization that has never properly articulated what it knows.

Discoverability Has Commercial Consequences

Executives research potential partners, healthcare professionals look for information, investors investigate companies and categories, candidates evaluate employers, procurement teams compare providers, journalists research unfamiliar subjects, and patients explore complex information environments. As AI-mediated research becomes another route into those activities, the quality of the information available about an organization can affect how it enters the consideration process.

The commercial question is therefore not simply, “Are we mentioned by AI?” A more useful question is: “When someone uses AI to understand a subject relevant to us, is there enough credible, current, and coherent information for us to be represented appropriately?” That framing matters because organizations can actually work on the underlying conditions.

AI Discoverability Needs to Be Maintained

Unlike a conventional website project, AI discoverability does not have a meaningful finish line. Organizations change, people move, products evolve, evidence develops, new content is published, terminology changes, external sources appear, and AI products change how they retrieve and present information.

Organizations should therefore periodically examine how important entities and areas of expertise are represented across AI-mediated discovery, identify material inaccuracies or gaps, trace those problems back to the underlying information environment where possible, and decide whether corrective action is justified. Not every imperfect AI answer requires intervention. The objective is not control, but to reduce significant ambiguity and strengthen the quality of the information from which machines and people form their understanding.

The JUYMO Perspective

At JUYMO, we treat AI discoverability as an extension of digital and commercial strategy rather than as a standalone optimization discipline. The fundamentals are relatively straightforward: create information worth finding, make important relationships clear, maintain factual and conceptual consistency, connect expertise to credible evidence, keep technical foundations sound, and understand that external authority matters as much as what an organization says about itself.

The technology around discovery will continue to change, while those principles are considerably more durable. For me, that is the practical opportunity behind AI discoverability: not learning how to speak to machines, but becoming clearer about what an organization wants both machines and people to understand.

Juan A. Flores, Co-Founder and CDO at JUYMO & Co.

CDO – Juan A. Flores

Juan A. Flores

About the author

Juan A. Flores is Co-Founder and CDO of JUYMO, with more than 25 years of experience in digital transformation across healthcare and other international industries. His work focuses on AI-enabled commercialization, GEO, AI discoverability, and digital governance, with particular interest in how changing information behavior affects organizations and commercial strategy.